ermium.com

Ermium Therapeutics

Ermium Therapeutics's email is contact@ermium.com .

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation. Ermium Therapeutics was founded in June 2019 by Jean-Philippe HERBEUVAL, Kurma Partners, Idinvest Partners, Domain Therapeutics and Erganeo. The company is based in Paris and has signed a worldwide exclusive license agreement on intellectual property from CNRS and University Paris Descartes (France) through an agreement with Erganeo, which supported the maturation of the project in a...

read more

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation. Ermium Therapeutics was founded in June 2019 by Jean-Philippe HERBEUVAL, Kurma Partners, Idinvest Partners, Domain Therapeutics and Erganeo. The company is based in Paris and has signed a worldwide exclusive license agreement on intellectual property from CNRS and University Paris Descartes (France) through an agreement with Erganeo, which supported the maturation of the project in an academic setting. In addition, Ermium Therapeutics recently won the innovation i-Lab 2019 award from the French Ministry of Research and Higher Education.

show less

View Top Employees for Ermium Therapeutics
img Website ermium.com
img Industry Biotechnology
img Employees 4
img HQ 16 bvd Saint Germain
img Email contact@ermium.com
img Funding 6,965,490 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website ermium.com
img Industry Biotechnology
img Employees 4
img LinkedIn linkedin.com/company/ermium-therapeutics
img HQ 16 bvd Saint Germain
img Email contact@ermium.com
img Funding 6,965,490 USD

Top Ermium Therapeutics Employees